Drug Shortage Report for MORPHINE SULFATE INJECTION SDZ
| Report ID | 134142 |
| Drug Identification Number | 02382997 |
| Brand name | MORPHINE SULFATE INJECTION SDZ |
| Common or Proper name | MORPHINE SULFATE INJECTION SDZ |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10LIAM V1 CA |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2021-02-12 |
| Estimated end date | 2021-03-12 |
| Actual end date | 2021-02-26 |
| Shortage status | Resolved |
| Updated date | 2021-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-03-02 | French | Compare |
| v3 | 2021-03-02 | English | Compare |
| v2 | 2021-02-16 | French | Compare |
| v1 | 2021-02-16 | English | Compare |
Showing 1 to 4 of 4